| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.7M | +67.5% |
| R&D Expense | $35.5M | +74.9% |
| SG&A Expense | $33.4M | -0.1% |
| Operating Income | -$67.2M | -27.5% |
| Interest Expense | $6.1M | +21.1% |
| Income Tax | $0 | — |
| Net Income | -$105.0M | -158.6% |
| EPS (Basic) | -$0.10 | -147.6% |
| EPS (Diluted) | -$0.10 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -54.1% |
| Current Assets | $9.4M | -45.5% |
| Total Assets | $31.3M | -22.0% |
| Current Liabilities | $126.0M | -5.8% |
| Long-term Debt | $21.5M | -33.5% |
| Total Liabilities | $136.4M | -16.9% |
| Stockholders' Equity | -$128.1M | -3.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.8M | -37.8% |
| Investing Cash Flow | -$2.9M | +51.8% |
| Financing Cash Flow | $42.0M | -12.8% |
| -66.7% |